Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy for Pancreatic Cancer
| BGUKX Fund | USD 5.72 0.00 0.00% |
Slightly above 56% of Baillie Gifford's investor base is looking to short. The analysis of overall sentiment of trading Baillie Gifford Discovery mutual fund suggests that many investors are alarmed at this time. Baillie Gifford's investing sentiment can be driven by a variety of factors including economic data, Baillie Gifford's earnings reports, geopolitical events, and overall market trends.
Baillie |
Zai Lab Limited and Novocure announced today that the pivotal, Phase 3 PANOVA-3 trial met its primary endpoi
Read at businesswire.com
 |
Baillie Gifford Fundamental Analysis
We analyze Baillie Gifford's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baillie Gifford using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baillie Gifford based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Baillie Gifford is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Baillie Gifford Discovery Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Baillie Gifford mutual fund to make a market-neutral strategy. Peer analysis of Baillie Gifford could also be used in its relative valuation, which is a method of valuing Baillie Gifford by comparing valuation metrics with similar companies.
Peers
Baillie Gifford Related Equities
| BSGPX | Eafe Pure | 0.08 | ||||
| BGCWX | Baillie Gifford | 0.07 | ||||
| BGCSX | Eafe Choice | 0.13 | ||||
| BGALX | Baillie Gifford | 0.31 | ||||
| BGASX | Global Alpha | 0.72 | ||||
| BTLKX | Baillie Gifford | 0.77 | ||||
| BGAKX | Global Alpha | 0.77 | ||||
| BGATX | Baillie Gifford | 0.77 | ||||
| BTLSX | Baillie Gifford | 0.78 | ||||
| BSGLX | Long Term | 1.26 |
Other Information on Investing in Baillie Mutual Fund
Baillie Gifford financial ratios help investors to determine whether Baillie Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Baillie with respect to the benefits of owning Baillie Gifford security.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |